Monte Rosa Therapeutics
Debora Bonenfant has a strong background in proteomics, with experience at Monte Rosa Therapeutics, Swiss Proteomics Society, and Novartis Institutes for BioMedical Research. Debora has held various positions such as Vice-President, Head of Proteomics, Senior Director, and Director of Proteomics. Debora's expertise includes supporting drug discovery projects, targeted protein degradation projects, target discovery and validation, pathway dissection, and project progression using proteomics approaches. Debora holds a Doctor of Philosophy (PhD) in Biochemistry and a DEA (Masters Degree) in Biology, Molecular Cellular and Genetics.
This person is not in any offices
Monte Rosa Therapeutics
2 followers
Monte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways.